Bausch + Lomb will pay $500 million in cash to...
Bausch + Lomb will pay $500 million in cash to buy ISTA Pharmaceuticals, which produces non-steroidal, anti-inflammatory, allergy, glaucoma and spreading agents and is based in Irvine, California. In addition to adding its products to B+L's complementary lineup of prescription ophthalmology and over-the-counter eye health products, ISTA's purchase will create ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.